Stockscreener 앱 받기
0.8453
6.08%
-0.0547
시간 외 거래:
.83
-0.0153
-1.81%
Allarity Therapeutics Inc 주식(ALLR)의 최신 뉴스
Biotechnology company Allarity Therapeutics Inc recently filed documents with the U.S. Securities and Exchange Commission, disclosing that its selling shareholders plan to resell 255,103 shares of the company’s common stock. - Bitget
What is the target price for Portman Ridge Finance Corporation stockInsider Selling & Real-Time Volume Spike Alerts - baoquankhu1.vn
Value Recap: What is the next catalyst for Allarity Therapeutics IncTrade Risk Summary & Risk Controlled Stock Alerts - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
Aug Setups: Will Wrap Technologies Inc face regulatory challengesJuly 2025 Weekly Recap & Entry Point Confirmation Signals - baoquankhu1.vn
Why analysts upgrade Allarity Therapeutics Inc. stock2025 Market Outlook & Daily Growth Stock Investment Tips - mfd.ru
Allarity Therapeutics Opens Enrollment for Phase 2 Trial in Lung Cancer - TradingView
Allarity begins phase 2 trial of stenoparib combination for lung cancer - Investing.com Nigeria
Allarity Therapeutics and US Veterans Administration open enrollment for mid-stage trial of stenoparib with temozolomide in relapsed small cell lung cancer - marketscreener.com
Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran’s Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment - ChartMill
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Can Allarity Therapeutics Inc. keep up with sector leadersJuly 2025 Weekly Recap & Intraday High Probability Alerts - baoquankhu1.vn
Published on: 2026-02-02 00:08:12 - baoquankhu1.vn
Published on: 2026-02-09 17:34:13 - baoquankhu1.vn
Can Allarity Therapeutics Inc. disrupt its industryChart Signals & Reliable Breakout Forecasts - mfd.ru
Published on: 2026-01-29 19:48:00 - mfd.ru
Allarity Therapeutics Secures Flexible Equity Financing Facility - TipRanks
Allarity Therapeutics Signs Common Stock Purchase Agreement With Tumim Stone Capital - TradingView
Activity Recap: Will Advanced Flower Capital Inc benefit from rising consumer demand2025 Performance Recap & Growth Oriented Trade Recommendations - baoquankhu1.vn
Can Allarity Therapeutics Inc disrupt its industryMarket Activity Report & Risk Controlled Swing Trade Alerts - baoquankhu1.vn
Short Interest in Allarity Therapeutics, Inc. (NASDAQ:ALLR) Declines By 17.1% - Defense World
Aug EndMonth: Is Allarity Therapeutics Inc backed by strong institutional buying2025 Analyst Calls & Risk Managed Investment Entry Signals - baoquankhu1.vn
Can Allarity Therapeutics Inc expand its profit margins2025 Major Catalysts & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Published on: 2026-01-16 10:01:32 - baoquankhu1.vn
Published on: 2026-01-16 08:05:07 - baoquankhu1.vn
Meme Stocks: Is Yuanbao Inc Depositary Receipt stock influenced by commodity pricesJuly 2025 Gainers & Reliable Price Action Trade Plans - baoquankhu1.vn
Market Outlook: What valuation multiples suggest for Allarity Therapeutics Inc stockJuly 2025 WrapUp & Weekly Stock Breakout Alerts - Bộ Nội Vụ
EV Market: Can Allarity Therapeutics Inc keep up with sector leadersProfit Target & Weekly Return Optimization Alerts - baoquankhu1.vn
Loss Report: Can Allarity Therapeutics Inc stock maintain growth trajectoryShare Buyback & Stepwise Trade Execution Plans - Bộ Nội Vụ
Reviewing Allarity Therapeutics (NASDAQ:ALLR) & Cardio Diagnostics (NASDAQ:CDIO) - Defense World
Market Wrap: What dividend safety score for Allarity Therapeutics Inc stockQuarterly Performance Summary & Technical Confirmation Alerts - Bộ Nội Vụ
What catalysts could drive Allarity Therapeutics Inc. stock higherJuly 2025 Weekly Recap & Weekly High Momentum Picks - Улправда
Allarity Therapeutics, Inc.Common stock (NQ: ALLR - FinancialContent
How Allarity Therapeutics Inc. stock benefits from tech adoptionMarket Risk Report & Growth Oriented Trade Recommendations - ulpravda.ru
How strong is Allarity Therapeutics Inc. stock balance sheetPrice Support Zones & Free Tap Rapid Wealth - Улправда
News | postregister.comAllarity Therapeutics, Inc.Common stock (Nasdaq:ALLR) Price Chart - FinancialContent
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on B - GuruFocus
Is Allarity Therapeutics Inc. stock a buy before product launches2026 world cup usa national team qualification young talents high defensive line winner prediction guide - ulpravda.ru
Allarity CEO says 2026 represents an ‘inflection point’ - Yahoo Finance
Allarity Therapeutics Issues 2025 End of Year CEO Letter to Shareholders - GlobeNewswire
Allarity Therapeutics, Inc. (NASDAQ:ALLR) Short Interest Down 21.9% in December - Defense World
Allarity Therapeutics Completes Additional Private Equity Financing - TipRanks
ALLR DEADLINE NOTICE: ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Allarity Therapeutics, Inc. Investors to Secure Counsel Before Important November 12 Deadline in Securities Class Action – ALLR - Macau Business
How Allarity Therapeutics Inc. stock reacts to Fed rate cutsEarnings Overview Summary & Smart Investment Allocation Tips - Улправда
Is Allarity Therapeutics Inc. stock oversold or undervalued2025 Stock Rankings & Smart Allocation Stock Tips - Улправда
Hedge Fund Bets: How Allarity Therapeutics Inc. stock reacts to Fed rate cuts2025 Major Catalysts & AI Optimized Trading Strategy Guides - Улправда
Will Allarity Therapeutics Inc. stock maintain dividend yieldJuly 2025 Final Week & High Conviction Investment Ideas - DonanımHaber
Is Allarity Therapeutics Inc. stock a bargain at current levels2025 Sector Review & Verified Stock Trade Ideas - Улправда
Published on: 2025-12-19 05:31:28 - Улправда
Allarity Therapeutics Earnings Notes - Trefis
Allarity Therapeutics Secures $2.5M Through Private Placement - MSN
Ascendiant Capital Maintains Allarity Therapeutics (ALLR) Buy Recommendation - Nasdaq
ALLR: Ascendiant Capital Raises Price Target, Maintains Buy Rati - GuruFocus
Allarity Therapeutics updates CFO employment agreement with full-time terms By Investing.com - Investing.com Australia
Allarity Therapeutics Appoints Jeffrey Ervin as Full-Time CFO - TipRanks
Allarity Therapeutics updates CFO employment agreement with full-time terms - Investing.com
Will Allarity Therapeutics Inc. stock benefit from sector rotationTrade Exit Summary & Trade Opportunity Analysis - Newser
1.24%
0.19%
자본화:
|
볼륨(24시간):